Global Ophthalmic Leader Moria is a global leader in ophthalmic microsurgery instruments, with a strong emphasis on microkeratomes for refractive surgery and corneal transplantation products. The company maintains a worldwide distribution platform and offices in the US, China, and Japan, creating ready-made channels for international partnerships with hospitals, eye banks, and experienced surgeons.

Growth Capital Backing Recent news shows Eurazeo Group acquiring a minority stake in Moria, signaling growth ambitions and potential for expansion into new markets and product lines. This environment may open doors for channel partnerships, co-developed instruments, and larger procurement opportunities through growth-capable financing.

Premium Niche Focus Moria’s specialization in high-precision ophthalmic instruments for corneal transplants, lamellar keratoplasty, and refractive surgery points to a high-value, repeatable purchasing cycle with opportunities to upsell disposables, maintenance programs, and surgeon-led training to secure long-term contracts.

Digital Procurement Ready The tech stack includes WooCommerce and Microsoft Dynamics, indicating an e-commerce and ERP/CRM-ready setup. This enables efficient B2B procurement partnerships, volume pricing, and smooth integration with hospital purchasing systems and partner portals.

Strategic Partnership Potential While competing with large ophthalmic players, Moria’s specialized product line and surgeon-driven innovation present a compelling case for exclusive distribution rights, joint marketing and training initiatives, and co-branded service offerings to accelerate adoption in key markets.